| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.067 | 0.8 |